A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

P. Rougier, M. Ducreux, D. Kerr, B. I. Carr, E. François, A. Adenis, L. Seymour

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)500-502
Number of pages3
JournalAnnals of Oncology
Issue number5
Publication statusPublished - May 1997


  • Chemotherapy
  • Hepatocellular carcinoma
  • Raltitrexed
  • Tomudex
  • Treatment outcome

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this